Key Takeaway: REDWOOD CITY, Calif., May 10, 2022 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (“Coherus”, Nasdaq: CHRS), announced today that senior management will present at the following investor conferences in May.
BofA Securities 2022 Healthcare Conference on Thursday, May 12 at 3:00 p.
Price reaction · baseline $8.03 (2022-05-09 close) · hit after-hours · 1 other CHRS headline(s) in the window, move may be shared
day 0 close · peak
+6.1%
day 1
-3.5%
day 3
-1%
Conference Participation Details
UBS Global Healthcare Conference
Date: November 11, 2025
Time: 8:45 a.m. ET
Format: Fireside Chat
How to Access
Investors and the general public can listen to both sessions live at:
Archived versions will be available following the live events for a limited time.
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+136%
120-day peak, hindsight
Typical move
6.6%
average across 12 past catalysts
Cash runway
~5 mo
High dilution risk
Lead asset
CHS-0214
Phase 3 · Rheumatoid Arthritis
Full Press Release Details
REDWOOD CITY, Calif., May 10, 2022 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (“Coherus”, Nasdaq: CHRS), announced today that senior management will present at the following investor conferences in May.
BofA Securities 2022 Healthcare Conference on Thursday, May 12 at 3:00 p.m. ET
UBS Global Healthcare Conference on Tuesday, May 24 at 2:00 p.m. ET
H.C. Wainwright Global Investment Conference on Wednesday, May 25 at 9:00 a.m. ET
Audio webcasts of these presentations will be available on the investors’ page of the Coherus website at http://investors.coherus.com. Please access the website prior to the start of the presentation to ensure a timely connection to the webcast. Each webcast will be archived on the Coherus website for 30 days.